Velan Capital Investment Management LP Milestone Pharmaceuticals Inc. Transaction History
Velan Capital Investment Management LP
- $89.2 Million
- Q1 2024
A detailed history of Velan Capital Investment Management LP transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Velan Capital Investment Management LP holds 650,000 shares of MIST stock, worth $858,000. This represents 1.3% of its overall portfolio holdings.
Number of Shares
650,000Holding current value
$858,000% of portfolio
1.3%Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
47Shares Held
31.3MCall Options Held
3.3KPut Options Held
3.5K-
Black Rock Inc. New York, NY4.97MShares$6.56 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$4.3 Million0.09% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.86MShares$3.77 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.37MShares$3.13 Million2.21% of portfolio
-
Lion Point Capital, LP New York, NY2.3MShares$3.04 Million2.63% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $39.6M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...